In the unadjusted model, a higher PI showed a trend towards increased recurrence risk (1.99, 0.78–5.10), which persisted with a slightly reduced magnitude after adjusting for clinical variables (1.77, 0.63–4.96).
← all excerpts
Identification and external validation of tumor DNA methylation panel for the recurrence risk stratification of stage II colon cancer.
1
—
—